Literatur
- 1
Krag D N, Weaver D L, Alex J C et al.
Surgical resection and radiolocalization of the sentinel lymph node in breast cancer
using a gamma probe.
Surg Oncol.
1993;
2
335
- 2
Kuehn T, Vogl F D, Helms G et al.
Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective
German multi-institutional trial.
Eur J Surg Oncol.
2004;
30
252
- 3
Kuehn T, Bembenek A, Decker T et al.
A concept for the clinical implementation of sentinel lymph node biopsy in patients
with breast carcinoma with special regard to quality assurance.
Cancer.
2005;
103
451
- 4 Kreienberg R, Kopp I, Albert U et al. Interdisziplinäre S3-Leitlinie für Diagnostik,
Therapie und Nachsorge des Mammakarzinoms.. 1. Aktualisierung ed München: Zuckschwerdt
Verlag GmbH; 2008
- 5
Krag D, Anderson S J, Julian T B et al.
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection
in clinically node-negative patients with breast cancer: overall survival findings
from the NSABP B-32 randomised phase 3 trial.
Lancet Oncol.
2010;
11
927
- 6
Van der Ploeg I, Nieweg O E, Van Rijk M C et al.
Axillary recurrence after a tumor-negative sentinel node biopsy in breast cancer patients:
A systematic review and meta-analysis of the literature.
Eur J Surg Oncol.
2008;
34
1277
- 7
Veronesi U, Viale G, Paganelli G et al.
Sentinel lymph node biopsy in breast cancer, ten year results of a randomized controlled
study.
Ann Surg.
2010;
251
595
- 8
Kim T, Giuliano A E, Lyman G H.
Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma,
a metaanalysis.
Cancer.
2006;
106
4
- 9
Bilimoria K Y, Bentrem D, Hansen N et al.
Comparison of sentinel lymph node biopsy alone and completion axillary lymph node
dissection for node-positive breast cancer.
J Clin Oncol.
2009;
27
2946
- 10
Giuliano A E, McCall L, Beitsch P et al.
Locoregional recurrence after sentinel lymph node dissection with or without axillary
dissection in patients with sentinel lymph node metastases: the American College of
Surgeons Oncology Group Z0011 randomized trial.
Ann Surg.
2010;
252
426
- 11
Giuliano A E, Hunt K, Ballman K V et al.
Axillary dissection vs no axillary dissection in women with invasive breast cancer
and sentinel node metastasis, a randomized clinical trial.
J Am Med Assoc.
2011;
305
569
- 12
Kuehn T, Poortmans P MP.
Z0011 – can we really abolish axillary dissection?.
Breast Care.
2011;
6
154
Dr. G. Helms
Universitätsfrauenklinik Tübingen
Calwerstr. 7
72076 Tübingen
eMail: gisela.helms@med.uni-tuebingen.de
